An experimental drug from Servier Pharmaceuticals significantly delayed the growth of a pernicious type of brain tumor, a major advance in a field that has made little progress for decades.
An experimental drug from Servier Pharmaceuticals significantly delayed the growth of a pernicious type of brain tumor, a major advance in a field that has made little progress for decades.